MedTrace Logo

PrEP iT! Mobile App Intervention

NCT04509076 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-07-07

Study results available
· View outcomes & findings →

Summary

The long-term goal of this research is to create an effective and sustainable program to support retention in PrEP care and PrEP adherence among 18-29 year old men who have sex with men (MSM). To reach this goal, we will develop and pilot test a mobile intervention tailored to young MSM, called PrEP iT! Primary aims include:

Aim 1: Develop the PrEP iT! mobile intervention through focus groups with young MSM and refine iterations through input from a community advisory board (CAB).

Aim 2: Conduct a pilot randomized controlled trial to assess the feasibility, acceptability and preliminary impact of the PrEP iT! intervention for young MSM.

Conditions

  • Treatment Adherence and Compliance

Interventions

BEHAVIORAL

PrEP iT! (plus usual PrEP care)

The PrEP iT! intervention is a mobile-optimized website, with the following components: * PrEP Adherence, PrEP Appointment, and Sexual Activity Self-Monitoring * Tailored feedback on PrEP adherence/non-adherence * PrEP and sexual health information tailored for YMSM * Text message reminders for PrEP adherence and healthcare appointments * An "ask the expert" feature

BEHAVIORAL

Usual PrEP care

Clinic visits every 3 months in the initial period following PrEP initiation, including HIV/STI screening and laboratory toxicity testing

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Hennepin Healthcare Research Institute

    collaborator OTHER

  • San Diego State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
29 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2022-04-15
Completion
2022-04-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04509076 on ClinicalTrials.gov